Skip Nav Destination
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
Issue Archive
September 12 2013
Table of Contents
INSIDE BLOOD
BLOOD WORK
PLENARY PAPER
REVIEW ARTICLE
REVIEW SERIES
CLINICAL TRIALS AND OBSERVATIONS
Evaluation of WHO criteria for diagnosis of polycythemia vera: a prospective analysis
Clinical Trials & Observations
IMMUNOBIOLOGY
LYMPHOID NEOPLASIA
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia
Alessandra Ferrajoli,Tait D. Shanafelt,Cristina Ivan,Masayoshi Shimizu,Kari G. Rabe,Nazila Nouraee,Mariko Ikuo,Asish K. Ghosh,Susan Lerner,Laura Z. Rassenti,Lianchun Xiao,Jianhua Hu,James M. Reuben,Steliana Calin,M. James You,John T. Manning,William G. Wierda,Zeev Estrov,Susan O’Brien,Thomas J. Kipps,Michael J. Keating,Neil E. Kay,George A. Calin
MYELOID NEOPLASIA
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies
Joshua J. Oaks,Ramasamy Santhanam,Christopher J. Walker,Steve Roof,Jason G. Harb,Greg Ferenchak,Ann-Kathrin Eisfeld,James R. Van Brocklyn,Roger Briesewitz,Sahar A. Saddoughi,Kyosuke Nagata,Robert Bittman,Michael A. Caligiuri,Omar Abdel-Wahab,Ross Levine,Ralph B. Arlinghaus,Alfonso Quintas-Cardama,John M. Goldman,Jane Apperley,Alistair Reid,Dragana Milojkovic,Mark T. Ziolo,Guido Marcucci,Besim Ogretmen,Paolo Neviani,Danilo Perrotti
PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS
PLATELETS AND THROMBOPOIESIS
THROMBOSIS AND HEMOSTASIS
Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Corien L. Eckhardt,Alice S. van Velzen,Marjolein Peters,Jan Astermark,Paul P. Brons,Giancarlo Castaman,Marjon H. Cnossen,Natasja Dors,Carmen Escuriola-Ettingshausen,Karly Hamulyak,Daniel P. Hart,Charles R. M. Hay,Saturnino Haya,Waander L. van Heerde,Cedric Hermans,Margareta Holmström,Victor Jimenez-Yuste,Russell D. Keenan,Robert Klamroth,Britta A. P. Laros-van Gorkom,Frank W. G. Leebeek,Ri Liesner,Anne Mäkipernaa,Christoph Male,Evelien Mauser-Bunschoten,Maria G. Mazzucconi,Simon McRae,Karina Meijer,Michael Mitchell,Massimo Morfini,Marten Nijziel,Johannes Oldenburg,Kathelijne Peerlinck,Pia Petrini,Helena Platokouki,Sylvia E. Reitter-Pfoertner,Elena Santagostino,Piercarla Schinco,Frans J. Smiers,Berthold Siegmund,Annarita Tagliaferri,Thynn T. Yee,Pieter Willem Kamphuisen,Johanna G. van der Bom,Karin Fijnvandraat,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group,for the INSIGHT Study Group
TRANSPLANTATION
HLA class II upregulation during viral infection leads to HLA-DP–directed graft-versus-host disease after CD4+ donor lymphocyte infusion
Sanja Stevanović,Cornelis A. M. van Bergen,Simone A. P. van Luxemburg-Heijs,Boris van der Zouwen,Ekaterina S. Jordanova,Alwine B. Kruisselbrink,Marian van de Meent,Jessica C. Harskamp,Frans H. J. Claas,Erik W. A. Marijt,Jaap Jan Zwaginga,Constantijn J. M. Halkes,Inge Jedema,Marieke Griffioen,J. H. Frederik Falkenburg
CORRESPONDENCE
ANKRD26-related thrombocytopenia and myeloid malignancies
Patrizia Noris,Remi Favier,Marie-Christine Alessi,Amy E. Geddis,Shinji Kunishima,Paula G. Heller,Paola Giordano,Karen Y. Niederhoffer,James B. Bussel,Gian Marco Podda,Nicola Vianelli,Rogier Kersseboom,Alessandro Pecci,Chiara Gnan,Caterina Marconi,Anne Auvrignon,William Cohen,Jennifer C. Yu,Akihiro Iguchi,Allison Miller Imahiyerobo,Francoise Boehlen,Dorsaf Ghalloussi,Daniela De Rocco,Pamela Magini,Elisa Civaschi,Ginevra Biino,Marco Seri,Anna Savoia,Carlo L. Balduini
Fcγ receptor IIB gene polymorphism in adult Japanese patients with primary immune thrombocytopenia
Takashi Satoh,Koji Miyazaki,Asako Shimohira,Naoki Amano,Yuka Okazaki,Tetsuya Nishimoto,Tohru Akahoshi,Shinichi Munekata,Yuhsaku Kanoh,Yasuo Ikeda,Masaaki Higashihara,Shinichiro Takahashi,Masataka Kuwana
-
Cover Image
Cover Image
![issue cover]()
Multicolor immunofluorescent staining for CD3 (clone PS1, IgG2a + IgG2a ALEXA 546) (red), CD8 (clone 4B11, IgG2b + IgGb ALEXA 647) (blue), and HLA class II (clone CR3/43, IgG1 + IgG1 ALEXA 488) (green) was performed on colonic biopsy from patient-2 obtained at the time of GVHD diagnosis after CD4+ DLI. Double CD3+CD8+ cells (purple) were defined as CD8+ T-cells, whereas CD3+CD8- expressing cells (red) were defined as CD4+ T-cells. Images were captured with a confocal laser scanning microscope (LSM510, Zeiss, Sliedrecht, The Netherlands) (×200 magnification) (supplemental Methods). See the article by Stevanović et al on page 1963.
- PDF Icon PDF LinkFront Matter
- PDF Icon PDF LinkTable of Contents
- PDF Icon PDF LinkBack Matter
- PDF Icon PDF LinkAdvertising
- PDF Icon PDF LinkEditorial Board
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals
